Pediatria

Diretriz para o diagnóstico laboratorial da deficiência de ferro em adultos (exceto gestantes) e crianças.

25 Nov, 2021 | 15:07h

Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children – British Journal of Haematology

---

OMS emite diretrizes sobre o tratamento de crianças com síndrome inflamatória multissistêmica associada a COVID-19.

24 Nov, 2021 | 11:37h

Comunicado de imprensa: WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19 – World Health Organization

Diretriz: Living guidance for clinical management of COVID-19 – World Health Organziation

Conteúdos relacionados:

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.

Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

---

Revisão sistemática | Vacinas para prevenção da diarreia causada por rotavírus.

24 Nov, 2021 | 11:06h

Vaccines for preventing rotavirus diarrhoea: vaccines in use – Cochrane Library

Resumo: Are rotavirus vaccines safe and effective in preventing rotavirus diarrhoea in infants and children? – Cochrane Library

Comentário: Vaccines for preventing rotavirus diarrhoea: an updated Cochrane review – Cochrane Library

---

Revisão | Prevenção de infecções emergentes em crianças.

23 Nov, 2021 | 15:33h

Prevention of Emerging Infections in Children – Pediatric Clinics of North America

---

[Ainda não publicado] Pesquisadores afirmam que dose única de vacina contra HPV é altamente eficaz – “Resultado de estudo randomizado e controlado no Quênia traz novo ânimo para eliminar o câncer de colo de útero no mundo.”

22 Nov, 2021 | 09:23h

Single-dose HPV vaccine highly effective, researchers say – University of Washington School of Medicine

Conteúdos relacionados:

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

---

M-A | Técnicas e tecnologias para melhorar os desfechos de cateter intravenoso periférico em pacientes pediátricos.

22 Nov, 2021 | 09:15h

Techniques and Technologies to Improve Peripheral Intravenous Catheter Outcomes in Pediatric Patients: Systematic Review and Meta-Analysis – Journal of Hospital Medicine (gratuito por tempo limitado)

---

Editorial | Vacinas contra COVID-19 para crianças – “Embora seja verdade que a maioria das crianças tenham doença assintomática ou leve, algumas ficarão bastante doentes e um pequeno número irá a óbito. Este é o motivo de crianças serem vacinadas contra gripe, meningite, catapora e hepatite.”

19 Nov, 2021 | 13:17h

COVID-19 vaccines for children – Science

Conteúdo relacionado: Review: Should children under 12 years of age be vaccinated against COVID-19?

 

Comentário no Twitter

"Although it is true that most children experience asymptomatic or mild COVID disease, some will get quite sick, and a small number will die.

It’s why children are vaccinated against influenza, meningitis, chickenpox, and hepatitis" @DrPaulOffit et al.https://t.co/mvXHXdiYha

— Madhu Pai, MD, PhD (@paimadhu) November 18, 2021

 

---

Causas globais, regionais e nacionais da mortalidade infantil (menores de 5 anos) em 2000-2019: análise sistemática atualizada com implicações para as Metas de Desenvolvimento Sustentável.

19 Nov, 2021 | 13:07h

Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals – The Lancet Child & Adolescent Health

 

Comentário no Twitter

Progress is still needed to improve child health and end preventable deaths among children <5 years

New cause-specific estimates of infant mortality for 2000-19 are explored in this Article by Jamie Perin and colleagues @JohnsHopkinsSPH, @LSHTM & @WHO https://t.co/QJEDAd5jYT pic.twitter.com/Wis0v8YSav

— The Lancet Child & Adolescent Health (@LancetChildAdol) November 18, 2021

Pneumonia remains #1 postneonatal killer for children <5. Most deaths occur in children who live in poverty or humanitarian settings, have poor access to quality care, are malnourished & unimmunised. Many health centres don’t have antibiotics or O2. It’s 2021 not the Middle Ages. https://t.co/P7EhDN9KJ2

— Fiona Russell (@Fiona_M_Russell) November 18, 2021

 

---

Relatório Clínico AAP | Promoção do uso do leite materno e da amamentação para bebês de muito baixo peso ao nascimento.

19 Nov, 2021 | 13:04h

Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant – Pediatrics

---

Relatório Clínico AAP | Biológicos para asma e doenças alérgicas cutâneas em crianças.

19 Nov, 2021 | 13:03h

Biologics for Asthma and Allergic Skin Diseases in Children – Pediatrics

---